Increasing IGFBP-3 levels in breast tumours may indicate adverse prognostic cancers, with contradictory implications on patient outcomes[B24,25] to reflect the complexity of IGFBP-3 effects on cell proliferation[B27,28,30]. The gene discussed is IGFBP3; the disease is cancer.